EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
01 1EUROAPI
02 2Coral Drugs Private Limited
03 1Vamsi Labs
04 1Axplora
05 1Sanofi
06 1LGM Pharma
07 1Seqens
08 1Symbiotec Pharmalab
09 1Jai Radhe Sales
10 1Aarti Pharmalabs
11 1Cennet Biopharma
12 1Century Pharmaceuticals
13 1TAPI Technology & API Services
14 1ALPS Pharmaceutical Ind. Co. Ltd.
15 1Amphastar Pharmaceuticals
16 1Apotex Pharmachem
17 1Aspire Lifesciences Pvt Ltd
18 2Aurisco Pharmaceutical
19 1Balaji Corporation
20 1Beijing Breathgreen Healthcare
21 2Breathgreen Pharmaceuticals
22 1CHEMO
23 1Chongqing Huapont Pharmaceutical
24 4Cipla
25 1Curia
26 1Dishman Carbogen Amcis
27 2GSK
28 1Grefuel
29 1Guangzhou Topwork Chemical
30 1Guangzhou Tosun Pharmaceutical
31 1Hikma Pharmaceuticals
32 2Hovione
33 1Industriale Chimica
34 1Jayco Chemical Industries
35 1Lupin Ltd
36 1Maiden Group
37 1Micro Orgo Chem
38 1NEWCHEM SPA
39 1PRG Pharma
40 1Ravico Pharmaceutical
41 1ScinoPharm Taiwan, Ltd
42 1Shandong Sito Bio-technology Co ltd
43 1Shouyuan Chemical
44 4Sterling Spa
45 1Sudarshan Pharma
46 1Sun Pharmaceutical Industries Limited
47 1Swati Spentose
48 1Taro Pharmaceutical Industries
49 1Teva Pharmaceutical Industries
50 1Tianjin Tianyao Pharmaceuticals Co., Ltd.
51 1Ultratech India Ltd.,
52 1Unimax Group
53 1Unipex
54 1Vaishali Pharma Ltd
55 1Viatris
56 1Xellia Pharmaceuticals ApS
01 1Canada
02 9China
03 1Denmark
04 4France
05 1Germany
06 28India
07 2Israel
08 6Italy
09 1Japan
10 2Portugal
11 1Spain
12 1Taiwan
13 7U.S.A
14 3United Kingdom
01 26Active
02 3Inactive
03 38Blank
01 3Expired
02 25Valid
03 2Withdrawn by Holder
04 37Blank
01 1218MF10834
02 1222MF10142
03 1223MF10176
04 1224MF10093
05 1302MF10118
06 1303MF10172
07 61Blank
01 1WC-0009
02 1WC-0099
03 1WC-0144nA2
04 1WC-0155
05 1WC-0157
06 1WC-0168
07 1WC-257
08 60Blank
Certificate Number : R1-CEP 2018-040 - Rev 00
Issue Date : 2023-05-03
Type : Chemical
Substance Number : 1750
Status : Valid
Registration Number : 303MF10172
Registrant's Address : 15 rue Traversie(')re 75012 Paris France
Initial Date of Registration : 2021-12-09
Latest Date of Registration : --
Registrant Name : Korea Mundipharma Co., Ltd.
Registration Date : 2024-05-31
Registration Number : 20240531-209-J-1652
Manufacturer Name : Euroapi France
Manufacturer Address : 4 Lieu Dit La Paterie, Vertolaye, 63480, France
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-05-11
Pay. Date : 2018-04-10
DMF Number : 21879
Submission : 2008-08-12
Status : Active
Type : II
Certificate Number : R1-CEP 2005-055 - Rev 03
Issue Date : 2020-09-25
Type : Chemical
Substance Number : 1750
Status : Valid
Date of Issue : 2022-09-16
Valid Till : 2025-07-05
Written Confirmation Number : WC-0009
Address of the Firm :
NDC Package Code : 49076-5501
Start Marketing Date : 2018-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
Certificate Number : CEP 2020-078 - Rev 02
Issue Date : 2023-12-11
Type : Chemical
Substance Number : 1750
Status : Valid
Date of Issue : 2022-06-13
Valid Till : 2025-07-02
Written Confirmation Number : WC-0155
Address of the Firm :
NDC Package Code : 66412-0679
Start Marketing Date : 2023-09-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-11-02
Pay. Date : 2018-10-31
DMF Number : 20463
Submission : 2007-04-24
Status : Active
Type : II
Certificate Number : CEP 2008-117 - Rev 02
Issue Date : 2024-05-23
Type : Chemical
Substance Number : 1750
Status : Valid
NDC Package Code : 46439-8729
Start Marketing Date : 2007-04-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R0-CEP 2013-158 - Rev 02
Issue Date : 2016-07-08
Type : Chemical
Substance Number : 1750
Status : Expired
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-23
Pay. Date : 2014-05-05
DMF Number : 15456
Submission : 2001-05-24
Status : Active
Type : II
Certificate Number : CEP 2007-192 - Rev 09
Issue Date : 2024-11-26
Type : Chemical
Substance Number : 1750
Status : Valid
Registration Number : 218MF10834
Registrant's Address : Offer Park, Building C, 4th floor, 94 Shlomo Shmeltzer Road, POB 3158, Petah Tikva 4970602, Israel
Initial Date of Registration : 2006-10-20
Latest Date of Registration : --
NDC Package Code : 58175-0361
Start Marketing Date : 2000-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Available Reg Filing : Canada DMF |
NDC Package Code : 22552-0043
Start Marketing Date : 2015-01-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-02
Pay. Date : 2013-03-11
DMF Number : 22980
Submission : 2009-07-22
Status : Active
Type : II
Certificate Number : R1-CEP 2007-262 - Rev 03
Issue Date : 2022-10-14
Type : Chemical
Substance Number : 1750
Status : Valid
Date of Issue : 2023-01-06
Valid Till : 2025-07-29
Written Confirmation Number : WC-0099
Address of the Firm :
NDC Package Code : 15308-0200
Start Marketing Date : 2005-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Flixotide Inhaler manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flixotide Inhaler, including repackagers and relabelers. The FDA regulates Flixotide Inhaler manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flixotide Inhaler API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flixotide Inhaler manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Flixotide Inhaler supplier is an individual or a company that provides Flixotide Inhaler active pharmaceutical ingredient (API) or Flixotide Inhaler finished formulations upon request. The Flixotide Inhaler suppliers may include Flixotide Inhaler API manufacturers, exporters, distributors and traders.
click here to find a list of Flixotide Inhaler suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 56 companies offering Flixotide Inhaler
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?